Table 1.
Patient characteristics
| All patients (n = 77) | % | |
|---|---|---|
| Male : Female | 55:22 | |
| Age, years median (IQR) | 65 (51–75) | |
| RRT vintage, months median (IQR) | 30 (14–66) | |
| HD vintage, months median (IQR) | 26 (11–49) | |
| Ethnicity | ||
| White | 68 | 88.3 |
| Black | 3 | 3.9 |
| South Asian | 3 | 3.9 |
| Other | 3 | 3.9 |
| Primary diagnosis | ||
| Glomerulonephritis | 24 | 31.2 |
| Diabetic nephropathy | 16 | 20.8 |
| Hypertensive/renovascular | 9 | 11.7 |
| Pyelonephritis/reflux | 5 | 6.5 |
| Polycystic disease | 4 | 5.2 |
| Renal dysplasia | 3 | 3.9 |
| Other or unknown | 16 | 20.8 |
| Smoker | 15 | 19.5 |
| Diabetes | ||
| Type 1 | 6 | 7.8 |
| Type 2 | 25 | 32.5 |
| Ischemic heart disease | 30 | 39.0 |
| Left ventricular hypertrophy | 16 | 20.8 |
| Listed for renal transplant | 19 | 24.7 |
| Antihypertensive medication | ||
| Angiotensin converting enzyme inhibitors (ACEi) | 16 | 20.8 |
| Aldosterone receptor blockers (A2RB) | 16 | 20.8 |
| Beta-blocker | 29 | 37.7 |
| Alpha-blocker | 12 | 15.6 |
| Calcium channel blocker | 26 | 33.8 |
| Other | 8 | 10.4 |
| Antihypertensives per patient | ||
| 0 | 23 | 29.9 |
| 1 | 14 | 18.2 |
| 2 | 31 | 40.3 |
| 3 | 5 | 6.5 |
| 4 | 4 | 5.2 |
HD = hemodialysis; IQR = interquartile range; RRT = Renal Replacement Therapy.